Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Japan Animal Referral Medical Center Co., Ltd. (6039:JPX), powered by AI.
Japan Animal Referral Medical Center Co., Ltd. is currently trading at ¥1,037. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Japan Animal Referral Medical Center Co., Ltd. on Alpha Lenz.
Japan Animal Referral Medical Center Co., Ltd.'s P/E ratio is 25.8.
“Japan Animal Referral Medical Center Co., Ltd. trades at a P/E of 25.8 (premium valuation) with solid ROE of 13.1%. 3Y revenue CAGR of 21.0% highlights clear growth momentum.”
Ask for details →Japan Animal Referral Medical Center Co., Ltd. is a specialized provider in veterinary healthcare services. It primarily focuses on offering state-of-the-art medical care for animals, with a particular emphasis on advanced diagnostic and therapeutic procedures. As a pivotal figure in the veterinary industry in Japan, the company facilitates cutting-edge treatments for complex medical conditions affecting a variety of pets. The center is equipped with modern medical infrastructure and technologies, catering to an increasing demand for specialized animal care due to the rising pet ownership and the humanization trend towards pets. By maintaining a network of skilled veterinarians and medical professionals, Japan Animal Referral Medical Center Co., Ltd. plays a significant role in enhancing the standard of veterinary care across the nation. Furthermore, the company's activities contribute to the broader sectors of pet care and lifestyle industries, making it an integral entity within Japan's expanding animal healthcare market.
“Japan Animal Referral Medical Center Co., Ltd. trades at a P/E of 25.8 (premium valuation) with solid ROE of 13.1%. 3Y revenue CAGR of 21.0% highlights clear growth momentum.”
Ask for details →Japan Animal Referral Medical Center Co., Ltd. (ticker: 6039) is a company listed on JPX in the Consumer Cyclical sector (Personal Services). It has approximately 294 employees. Market cap is $13.4B.
The current price is 1,037 with a P/E ratio of 25.78x and P/B of 3.24x.
ROE is 13.09% and operating margin is 13.66%. Annual revenue is $5.3B.